Compare
Up to four compounds, side by side.
Search or pick a starting set. Differences light up so you can spot them fast.
PT-141
1 / 4
Peptide
Melanocortin Agonist
PT-141Overview
Summary
Centrally-acting libido peptide — FDA-approved for premenopausal HSDD.
Category
Melanocortin Agonist
Mechanism
MC4R agonist that acts centrally on sexual desire pathways, independently of vascular flow.
Effects
Top outcomes
- Libido90
Evidence
Established
Practical
Half-life
~2 hours
Administration
subqnasal
Risk
Legal status
rx only
Safety
Nausea, flushing, and transient blood-pressure increase reported.
Try a preset